Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey

OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Q, Oladapo, OT, Leathersich, S, Vogel, JP, Carroli, G, Lumbiganon, P, Qureshi, Z, Gülmezoglu, AM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
General Obstetrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697690/
https://www.ncbi.nlm.nih.gov/pubmed/27885772
http://dx.doi.org/10.1111/1471-0528.14400
Descripción
Sumario:OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total of 147 health facilities in 15 countries across Africa, Latin America and Asia. POPULATION: Heads of obstetric departments or maternity units. METHODS: Anonymous online and paper‐based survey conducted in 2015. MAIN OUTCOME MEASURES: Availability and use of MgSO (4); availability of a formal clinical protocol for MgSO (4) administration; and MgSO (4) dosing regimens for eclampsia prevention and treatment. RESULTS: Magnesium sulphate and a formal protocol for its administration were reported to be always available in 87.4% and 86.4% of all facilities, respectively. MgSO (4) was used for the treatment of mild pre‐eclampsia, severe pre‐eclampsia and eclampsia in 24.3%, 93.5% and 96.4% of all facilities, respectively. Regarding the treatment of severe pre‐eclampsia, 26.4% and 7.0% of all facilities reported using dosing regimens that were consistent with Zuspan and Pritchard regimens, respectively. Across regions, intramuscular maintenance regimens were more commonly used in the African region (45.7%) than in the Latin American (3.0%) and Asian (22.9%) regions, whereas intravenous maintenance regimens were more often used in the Latin American (94.0%) and Asian (60.0%) regions than in the African region (21.7%). Similar patterns were found for the treatment of eclampsia across regions. CONCLUSIONS: The reported clinical use of MgSO (4) for eclampsia prevention and treatment varied widely, and was largely inconsistent with current international recommendations. TWEETABLE ABSTRACT: MgSO (4) regimens for eclampsia prevention and treatment in many hospitals are inconsistent with international recommendations.

Ejemplares similares